USPTO serial 90265690
CHIVD CHEMCLIN DIAGNOSTICS CORPORATION
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JAGANNATHAN, SIDDHARTH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CHIVD CHEMCLIN DIAGNOSTICS CORPORATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leo M. Loughlin
Leo M. Loughlin ROTHWELL, FIGG, ERNST & MANBECK, PC901 New York Avenue, N.W.Suite 900 EastWASHINGTON, DC 20001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents and contrast media for medical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic reagents for medicinal use; Diagnostic preparations for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes; Pharmaceutical preparations for medical purposes for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH | ACTIVE | — |
| 010 | Medical devices for use in treating or diagnosing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for detecting cancer; Diagnostic apparatus for the detection of cancer; Medical instrument for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic apparatus for testing DNA, protein, Antigen, antibody, whole blood, serum and plasma; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical apparatus and instruments for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCH | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CHEMCLIN DIAGNOSTICS CO., LTD.
- Other trademarks owned by CHEMCLIN DIAGNOSTICS CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CHIVD CHEMCLIN DIAGNOSTICS CORPORATION
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 4, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 24, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 22, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 22, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 22, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 18, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 18, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 19, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 15, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 15, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 15, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 19, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 19, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 19, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 24, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2020 | NWAP | NEW APPLICATION ENTERED | — |